iBio to Participate in Upcoming Investor Conferences
Globe Newswire•02/11/2026•16:30 ET
0
Key Highlights
- ➤iBio executives to participate in three healthcare investor conferences
- ➤Martin Brenner and Felipe Duran scheduled for fireside chats and meetings
- ➤Conference appearances span November 9 through December 3, 2026
SAN DIEGO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary diseases, today announced that Martin Brenner, DVM, Ph.D., Chief Executive Officer and Chief Scientific Officer, and Felipe Duran, Chief Financial Officer, will participate in the following investor conferences in November and December 2026.
Guggenheim Healthcare Innovation 2026 Conference When: November 9 - 11 Format: Fireside chat Date & Time: November 10, 2026: 9:00 a.m. ET Location: Boston
Get started
Create a free account to read the full story.